Report your medication side effects through the Yellow Card scheme Date 25 September 2023 We’re promoting the Yellow Card scheme to the Parkinson’s community, to make sure everyone knows where to report any medication side effects they may experience.
Next phase of cannabidiol (CBD) trial for Parkinson’s non-motor symptoms needs participants in the UK Date 15 September 2023 The study builds on the results from the pioneering Parkinson’s UK funded trial launched in 2019.
New risk factor for Parkinson’s identified among people of African descent Date 31 August 2023 A global collaboration of researchers has found a specific gene change is a risk factor for Parkinson’s unique to the Black African community.
New blood test shows promise for detecting Parkinson’s Date 30 August 2023 The new test can detect problems with mitochondria in blood cells and could one day be used to diagnose Parkinson’s.
Positive results announced from early stage stem cell therapy trial Date 28 August 2023 A study in people with Parkinson’s suggests the stem cell based treatment is safe and improves symptoms of the condition.
Certain gut conditions may be an early sign of Parkinson’s Date 25 August 2023 Researchers compared medical records of over 92,000 people in the US with Parkinson’s, other neurological conditions and those without any, to show certain gut conditions increase the risk of Parkinson’s.
Eye scans detect signs of Parkinson’s up to 7 years before diagnosis Date 22 August 2023 Largest study on retinal imaging in Parkinson’s identifies markers of Parkinson’s in eye scans with the help of artificial intelligence (AI).
Researchers use AI to predict different drivers of Parkinson’s Date 17 August 2023 The AI examined images of brain cells and was able to identify changes in key areas of the cell that are characteristic of the different known mechanisms that cause Parkinson’s.
Clinical trial results offer hope of a new Parkinson’s treatment for motor symptoms and dyskinesia Date 7 July 2023 Updated trial results show NLX-112 could treat motor symptoms as well as dyskinesia. If further trials are successful, we could have a valuable new Parkinson’s drug by 2030.
Positive results from an early clinical trial for a drug boosting cell batteries in people with Parkinson’s Date 12 June 2023 Results from a UK phase 2 clinical trial show that ursodeoxycholic acid (UDCA) is safe for people with Parkinson's and can increase energy production in cells in the brain.
